COVID-19: Antibodies and Vaccine
The Mount Sinai panel discusses the current state of development of vaccines for COVID-19, and the particular challenges the virus poses. With more than 70 vaccines in development, the panel outlines the various approaches and their promise.
Published
May 1, 2020
Created by
Featured Faculty
Irene Heinz Given and John LaPorte Given Professor
Chair of the Lillian and Henry M. Stratton-Hans Popper Department of Pathology
Molecular and Cell-Based Medicine
Icahn School of Medicine at Mount Sinai
Director, Global Health and Emerging Pathogens Institute
Irene and Dr. Arthur M. Fishberg Professor, Microbiology, and Medicine (Infectious Diseases)
Icahn School of Medicine at Mount Sinai
Valentin Fuster, MD, PhD, MACC
Physician-in-Chief, The Mount Sinai Hospital
President, Mount Sinai Fuster Heart Hospital
Richard Gorlin, MD Heart Foundation Professor of Cardiology
Editor-in-Chief of the Journal of the American College of Cardiology (2014-2024)
Associate Professor, Medicine (Infectious Diseases)
Icahn School of Medicine at Mount Sinai
The Philip J. and Harriet L. Goodhart Chair in Cardiology Associate Dean for Global Health; Professor, Radiology Director, Cardiovascular Imaging Program, Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai